Given Imaging: (NASD: GIVN)

$15.40

0.04 (0.26%)

Volume 47,075

May 17 04:00 PM ET

Zacks Rank: 4-Sell

Zacks Rank	Definition	Annualized Return
#1	Strong Buy	26.6%
#2	Buy	18.71%
#3	Hold	10.12%
#4	Sell	4.32%
#5	Strong Sell	2.16%
S&P	500	9.93%

Overview Quote

            Stock Activity
        
		Day Low - High
		15.25 - 15.45
	
		52wk Low - High
		12.14 - 19.48
	
		Previous Close
		15.36
	
		Avg. Volume
		44,764
	
		Industry
		MED INSTRUMENTS
	
		Market Cap
		479.36 M
	
		Div - Yield
		0.00 - 0.00
	
		Beta
		1.26
	
		PE (Forward)
		25.25
	
		Current Year Est.
		0.61
	
		Quarterly Earnings ESP 
		0.00%
	
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

                Premium research
            
		Zacks Rank  Short-Term: 1-3 Months
                                                                
                                                                Zacks #1 Rank Strong Buys
                                                                
                                                            This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below. 

                                                                        Zacks Rank
                                                                        Definition
                                                                        Annualized Return
                                                                    
                                                                        #1
                                                                        Strong Buy
                                                                        26.6%
                                                                    
                                                                        #2
                                                                        Buy
                                                                        18.71%
                                                                    
                                                                        #3
                                                                        Hold
                                                                        10.12%
                                                                    
                                                                        #4
                                                                        Sell
                                                                        4.32%
                                                                    
                                                                        #5
                                                                        Strong Sell
                                                                        2.16%
                                                                    
                                                                        S&P
                                                                        500
                                                                        9.93%
                                                                    
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank
                                                        
		4
Sell

		Zacks Recommendation  Long-Term: 6+ Months
                                                                
                                                                All Outperform Rated Stocks
                                                                
                                                            Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.
The Zacks Recommendations are split into 3 groups: Buy, Hold and Sell. Our Buy recommendations have generated returns of 34.4% in 2006, and 16.69% in 2007. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock.    More on these reports below.

                                                                    Difference Between Zacks Rank and Zacks Recommendation

                                                                    Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations
                                                                
		Neutral
	
		Zacks Industry Rank Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.
When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

                                                                About Zacks Industry Rank

                                                                Zacks Industry Rank - All current industry ranks. 

                                                                Zacks Premium - The only way to get access to the Zacks Industry Rank
                                                            
		114 out of 265
	
		Equity Research Report The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

                                        Zacks Equity Research Home
                                        Zacks Premium - The only way to get access to Zacks Recommendations
                                    
Updated as of NA

		PREMIUM
	
    (  = Change in last 30 days) 
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial 
Zacks Premium Home | Zacks Rank Stock Education

                Key Earnings Data
            
                            PE (Forward)
                            25.25
                        
                            PEG Ratio
                            NA
                        
                            Current Year Est.
                            0.61
                        
                            Current Quarter Estimate
                            0.17
                        
                            Most Accurate Estimate
                            0.17
                        
                            Earnings ESP 
                            0.00%
                        
                            Next Earnings Report Date
                            08-06-2013
                        
                            EPS Last Year
                            0.56
                        
                            Expected Earnings Growth
                            NA
                        
Earnings ESP (Expected Surprise Prediction) is Zacks' proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement. The Earnings ESP shows the percentage difference between the Most Accurate Estimate and the Consensus.

            Company Description
        
Given Imaging Ltd. developed the Given System, a proprietary wireless imaging system that represents a fundamentally new approach to visual examination of the gastrointestinal tract. This system uses a miniaturized video camera contained in a capsule that is ingested by the patient and delivers high quality color images in a painless and noninvasive manner.   
Full GIVN Company Report

        
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

            Interactive Java Charting | Fundamental Charts
        
            <a href="#"><img id="dart_image_1" src="http://b7d61a7c6b8c307bf531-a92a66b9587e2a0aa805bd4e70b98407.r95.cf2.rackcdn.com/images/zacks/logos/zacks_logo_230x76.png" width="336" height="280" border="0" alt="" /></a>        
Turn Earnings Surprises into quick profits.
 
GIVN Chart  by YCharts

Earnings Estimates

	Current Qtr (06/2013)	Next Qtr (09/2013)	Current Year (12/2013)	Next Year (12/2014)
Average Estimate	0.17	0.20	0.61	0.78
Number of Estimates	1	1	1	1
Low Estimate	0.17	0.20	0.61	0.78
High Estimate	0.17	0.20	0.61	NA
Year Ago EPS	0.16	0.20	0.52	0.61
EPS Growth	6.25%	0.00%	17.31%	27.87%

More GIVN Estimates

Average Earnings Estimates for GIVN

EPS Growth for GIVN

Industry Analysis

Name	Symbol	Previous Close
GIVEN IMAGING	GIVN	15.40
NATUS MEDICAL	BABY	14.36
CRYOLIFE INC	CRY	6.34
DELCATH SYS INC	DCTH	0.41
GLOBUS MEDICAL	GMED	15.69
HEARTWARE INTL	HTWR	99.19
MELA SCIENCES	MELA	1.07
OXYSURE SYSTEMS	OXYS	0.90
PACIFIC BIOSCI	PACB	2.42
SUNSHINE HEART	SSH	5.49

Sector:Medical>> Industry:MED INSTRUMENTS

COMPARE TICKER vs. Its Peers

Zacks Commentary

Biolase Gets FDA Nod for EPIC 10S

Apr 15, 2013

Haemonetics Back to Neutral

Apr 15, 2013

Cyberonics Stands Out at Outperform

Apr 12, 2013

Thoratec Upgraded to Neutral

Apr 12, 2013

FDA Approves TFX's ISO-Gard Mask

Apr 12, 2013

LIFE Takeover Battle Heats Up

Apr 11, 2013

Will Thermo Fisher Buy LIFE?

Apr 10, 2013

New Bioinformatics Tools by LIFE

Apr 10, 2013

More GIVN Zacks Commentary

Financials

EPS TTM	0.56
Sales	181
Net Income	14
Price/Earnings	27.50
Price/Book	2.13
Price/Cash Flow	18.92
Price/Sales	2.67

More GIVN Financials

News

Stock Investors Sell Off Shares of Given Imaging, Down 1.7% - Financial News Network Online - Market Movers

May 16, 2013

This Forgotten Stock Could Kick Off a Big Rally Next Week - StreetAuthority

May 16, 2013

Highest EBITDA Growth in the Health Care Equipment Industry Detected for Solta Medical (SLTM, BABY, GIVN) - Financial News Network Online - News Corner

May 14, 2013

Given Imaging Announces Extensive Data From More Than 140 Abstracts to Be Presented at Digestive Disease Week(R) 2013 - Globenewswire

May 13, 2013

Given Imaging LtdCorporate Event Announcement Notice - Wall Street Horizon

May 10, 2013

Given Imaging is Among the Companies in the Health Care Equipment Industry With the Lowest PEG Ratio (GIVN, OFIX, ABMD) - Financial News Network Online - News Corner

May 10, 2013

Given Imaging LtdCorporate Event Announcement Notice - Wall Street Horizon

May 9, 2013

Shares of Given Imaging Under Pressure, Down 3.6% - Financial News Network Online - Market Movers

May 9, 2013

See All News Stories on GIVN

Broker Recommendations

Current ABR	1.00
ABR (Last Week)	1.00
# of recs in ABR	1
Average Target Price	22.00
Industry Rank by ABR	114 out of 265
Rank in Industry	44 out of 52

More GIVN Broker Recommendations

Day Low - High	15.25 - 15.45
52wk Low - High	12.14 - 19.48
Previous Close	15.36
Avg. Volume	44,764
Industry	MED INSTRUMENTS
Market Cap	479.36 M
Div - Yield	0.00 - 0.00
Beta	1.26
PE (Forward)	25.25
Current Year Est.	0.61
Quarterly Earnings ESP	0.00%

PE (Forward)	25.25
PEG Ratio	NA
Current Year Est.	0.61
Current Quarter Estimate	0.17
Most Accurate Estimate	0.17
Earnings ESP	0.00%
Next Earnings Report Date	08-06-2013
EPS Last Year	0.56
Expected Earnings Growth	NA

Username: Password:

Remember me [?]

Given Imaging: (NASD: GIVN)

$15.40

0.04 (0.26%)

Volume 47,075

May 17 04:00 PM ET

Stock Activity

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks Recommendation Long-Term: 6+ Months

Zacks Industry Rank

Equity Research Report

Key Earnings Data

Company Description

Earnings Estimates

Industry Analysis

Sector:Medical>> Industry:MED INSTRUMENTS

Zacks Commentary

Financials

News

Broker Recommendations